Successful Treatment of Refractory Vitiligo With a Combination of Khellin and 308-Nm Excimer Lamp: An Open-Label, 1-Year Prospective Study

Dermatology and Therapy - Germany
doi 10.1007/s13555-017-0218-x
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

007������308 Nm Excimer Laser for the Treatment of Scalp Psoriasis

Photodermatology Photoimmunology and Photomedicine
Nuclear MedicineRadiologyImmunologyAllergyMedicineImagingDermatology
2002English

Low-Dose Excimer 308-Nm Laser for Treatment of Lichen Planopilaris

Archives of Dermatology
2011English

Topical Tacrolimus and the 308-Nm Excimer Laser

Archives of Dermatology
2004English

An Open-Label, Prospective Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Long-Term Treatment of Refractory Depression

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2008English

Onabotulinumtoxin a Treatment of Drooling in Children With Cerebral Palsy: A Prospective, Longitudinal Open-Label Study

Toxins
MutagenesisToxicologyHealth
2015English

Effectiveness of the 308-Nm Excimer Laser on Hypopigmentation After Lichen Striatus: A Retrospective Study of 12 Patients

Journal of the American Academy of Dermatology
Dermatology
2016English

The Efficacy of Vitamin D3 Supplementation in Increasing 25-Hydroxyvitamin D Levels in Childhood Vitiligo Patients Receiving 308-Nm-Excimer Light Phototherapy

Dermatology Reports
Dermatology
2019English

Rufinamide for Refractory Focal Seizures: An Open-Label, Multicenter European Study

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2013English

Enduring Efficacy and Tolerability of Daratumumab in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma ( GEN 503): Final Results of an Open‐label, Phase 1/2 Study

British Journal of Haematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy